Table 1

The input values for clinical options for breast cancer detection derived from a literature search

Proposed Diagnostic Tests/Assays

SN

SP

Cost($)

Reference

PMID


Magnetic Resonance Imaging (MRI)

0.96

0.75

100.00

Imbriaco et al. 2001 [11]

11202453

Electrical Impedance Scanning

0.38

0.95

100.00

Stojadinovic et al., 2006 [12]

16491309

electronic resonance spectroscopy of albumin configuration

0.85

0.91

100.00

Seidel et al., 2005 [13]

16422355

SCM Test

0.81

0.85

100.00

Klein et al., 2002 [14]

14965713

Serum TSGF

0.6386

0.9089

100.00

Liang et al., 2002 [15]

12526228

mammaglobin (cutpoint 8.8)

0.688

0.888

100.00

Bernstein et al., 2005 [16]

16166429

SELDI (serum), CART, two surfaces

0.9

0.93

100.00

Vlahou et al., 2003 [17]

14499014

scintimammography on px w/suspicious breast mass

0.9

0.938

100.00

Polan et al., 2001 [18]

11353112

NAS bFGF, race, menopausal status + PSA

0.909

0.833

100.00

Hsiung et al., 2002 [19]

12184408

cytology alone, breast ductal lavage cells

0.67

0.93

100.00

Zhang et al., 2006 [20]

16477639

G-actin biomarker, breast ductal lavage cells

0.9

1

100.00

Zhang et al., 2006 [20]

16477639

DNA5cER biomarker, breast ductal lavage cells

1

0.93

100.00

Zhang et al., 2006 [20]

16477639


Shi and Lyons-Weiler BMC Medical Informatics and Decision Making 2007 7:23   doi:10.1186/1472-6947-7-23

Open Data